Edition:
United Kingdom

Xenetic Biosciences Inc (XBIO.OQ)

XBIO.OQ on NASDAQ Stock Exchange Capital Market

1.98USD
17 Jan 2019
Change (% chg)

$-0.07 (-3.41%)
Prev Close
$2.05
Open
$2.03
Day's High
$2.04
Day's Low
$1.98
Volume
2,880
Avg. Vol
14,754
52-wk High
$8.94
52-wk Low
$1.45

Chart for

About

Xenetic Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on discovery, research and development of biologic drugs and novel oncology therapeutics. The Company’s lead investigational product candidate is oncology therapeutic XBIO-101, which is used for the treatment of progestin - resistant... (more)
No analyst recommendations are available for .

Overall

Beta: 1.30
Market Cap(Mil.): $25.89
Shares Outstanding(Mil.): 8.72
Dividend: --
Yield (%): --

Financials

  XBIO.OQ Industry Sector
P/E (TTM): -- 69.71 33.71
EPS (TTM): -1.48 -- --
ROI: -72.68 8.99 14.48
ROE: -141.57 10.13 15.99

Earnings vs. Estimates